Disease modifying treatment available:
Time critical diagnosis and management:
Lateralising:
Dermatomyositis may cause the following:
1) The term dermatomyositis encompasses a clinically and biochemically heterogenous group of disorders. What categorisation is optimal for determining management and prognosis?
2) What role do auto-antibodies have in the stratification of dermatomyositis?
3) There appears to be an overlap between dermatomyositis and motor neurone disease. They share some common features such as sparing of the extra-ocular muscles. What is the pathophysiological basis of this overlap?